SAHPRA

What SAHPRA does

SAHPRA (South African Health Products Regulatory Authority) is a statutory regulatory body established in 2018 under the Medicines and Related Substances Act, 1965 (Act 101 of 1965), operating as a semi-independent agency under the supervision of the South African National Department of Health. Headquartered in Pretoria with 501-1,000 employees, SAHPRA is the sole national authority for regulating health products in South Africa, with exclusive statutory responsibility for the registration, licensing, inspection, and post-market surveillance of medicines, medical devices, in-vitro diagnostics, radiation-emitting devices, biological products, complementary medicines, and veterinary medicines. The authority's "customers" are statutory in nature: pharmaceutical manufacturers, medical device companies, clinical trial sponsors, healthcare professionals, and the South African public, all of whom are required to interact with SAHPRA's regulatory processes by law.

SAHPRA operates an extensive digital platform ecosystem to support its regulatory mandate. Core submission infrastructure includes the eCTD Submissions Portal for electronic regulatory dossier submissions, the SAHPRA Engagement Portal for variation and renewal applications, the Variations Portal for post-registration changes, the Complementary Medicines Licensing Portal, and the Section 21 Applications Portal for access to unregistered medicines. Public-facing assets include the Registered Health Products Database, the Online Medicine Directory (MedsInfo), and the PI & PIL Repository, while pharmacovigilance and surveillance capabilities are delivered through the Med Safety App, the AEFI Reporting Dashboard, the COVI-VIG system, and the Mpox Monitoring Portal. The organization also runs self-service status checkers and a Service Desk system for industry support, and publishes a public Backlog clearance program under a formal Digital Transformation initiative.

SAHPRA's revenue model is built on regulatory service fees — application fees, retention fees, clinical trial approval fees, establishment licensing fees, and certificate of free sale issuance — supplemented by government appropriation through the National Department of Health. The organization does not sell products or services in a commercial sense, has no private shareholders, and is governed by a board appointed by the Minister of Health. CEO Dr. Boitumelo Semete-Makokotlela leads the executive team. SAHPRA participates in international regulatory harmonization through partnerships with WHO (including the WHO Collaborative Procedure and WHO-UMC pharmacovigilance systems), the African Medicines Regulatory Harmonisation (AMRH) initiative, the ZAZIBONA joint evaluation procedure, and the African Medicines Agency (AMA), and collaborates domestically with the South African Pharmacy Council (SAPC) on enforcement actions targeting unlawful manufacturing and distribution.

Name

SAHPRA

Legal name

South African Health Products Regulatory Authority

Website

https://sahpra.org.za

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

501–1,000 employees

Short description

SAHPRA is South Africa's statutory health products regulator, overseeing registration, licensing, and post-market surveillance of medicines, medical devices, biologicals, and complementary medicines. It operates a multi-portal digital ecosystem serving pharmaceutical companies, clinical trial sponsors, healthcare professionals, and the public.

Ownership category

akta.pro rank

Product category

Health Products Regulatory Authority

NAICS

Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors (926150), Administration of Public Health Programs (923120)

akta.pro industry

PRIMARYHLAJADAA

Drug Regulators (Human Pharmaceuticals)

Healthcare & Life Sciences/Public Health, Government & Regulators/Medicines & Healthcare Product Regulators (Drugs/Biologics/Devices)

SECONDARYHLAJADAF

Clinical Trials Authorization & Oversight (GCP)

Healthcare & Life Sciences/Public Health, Government & Regulators/Medicines & Healthcare Product Regulators (Drugs/Biologics/Devices)

SECONDARYHLAGAKAH

Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

SECONDARYHLAGALAJ

PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Pharmacovigilance & Medical Affairs Services

SECONDARYHLAAAEAK

Clinical Development & Regulatory for Vaccines (trials, pharmacovigilance, lot release)

Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics

SECONDARYHLAJAHAM

Consent, Documentation & Certification (Records/Passports/Proof of Vaccination)

Healthcare & Life Sciences/Public Health, Government & Regulators/Immunization Programs & Vaccine Administration

Keywords

• Health products regulation
• Medicines registration
• Clinical trial approvals
• Pharmacovigilance services
• Medical device licensing

Headquarters

HQ city

Pretoria

HQ country

South Africa

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Regulatory Service Fees: SAHPRA generates revenue through fees charged for regulatory services including product registration applications, variation applications, retention fees, clinical trial approvals, establishment licences, and certificate of free sale issuance

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Core offering

SAHPRA is the statutory national regulatory authority for health products in South Africa, providing registration, licensing, and inspection services for medicines, medical devices, in vitro diagnostics, biologicals, complementary medicines, veterinary medicines, and radiation-emitting devices. It evaluates and approves clinical trial applications, monitors product safety through pharmacovigilance and adverse event reporting, and issues certificates of free sale, all delivered through a suite of digital portals and databases.

Product overview

SAHPRA (South African Health Products Regulatory Authority) operates as a regulatory body rather than a commercial product company. Its digital ecosystem consists of multiple interconnected web portals and databases that serve the pharmaceutical and health products regulatory lifecycle. The core platforms include the eCTD Submissions Portal for electronic regulatory dossier submissions, the SAHPRA Engagement Portal for variation and renewal applications, and the Variations Portal for post-registration changes. Supporting these are the Complementary Medicines Licensing Portal, Section 21 Applications Portal, and Product Variations Portal. Public-facing databases include the Online Medicine Directory (MedsInfo), Registered Health Products Database, and PI & PIL Repository. The suite also includes surveillance tools (Mpox Monitoring Portal, AEFI Reporting Dashboard, COVI-VIG Reporting System, Med Safety App) and self-service status checkers for applications and variations. These systems collectively support SAHPRA's mandate to regulate medicines, medical devices, biological products, and complementary medicines in South Africa.

Differentiator

Problem solved

Functional benefit

Brands

• Med Safety App: Mobile application for reporting side effects of health products and immunizations
• SAHPRA Engagement Portal
• eCTD Submissions Portal
• SAHPRA Variations Portal
• Mpox Monitoring Portal

Products and services

• eCTD Submissions Portal Electronic Common Technical Document portal for pharmaceutical companies to submit regulatory dossiers for medicine registration in a standardised format.
• SAHPRA Engagement Portal Online portal for industry stakeholders to submit variation, renewal, and response applications for registered health products and track their status.
• Variations Portal Digital platform for submitting and managing post-registration variation applications for health products, with dedicated technical support helpdesk.
• Med Safety App Mobile application for healthcare professionals and consumers to report adverse drug reactions and side effects to SAHPRA.
• Complementary Medicines Licensing Portal Dedicated portal for licensing and application submission for complementary medicines in South Africa.
• Section 21 Applications Portal Portal for applying for Section 21 permits to access unregistered medicines for specific patient needs.
• Online Medicine Directory (MedsInfo) Online directory providing healthcare professionals and consumers with information on all SAHPRA-registered over-the-counter and prescription medicines available in South Africa.
• Registered Health Products Database Comprehensive searchable database of all health products registered by SAHPRA.
• PI & PIL Repository Repository of Patient Information Leaflets and Package Insert documents for registered health products.
• Mpox Monitoring Portal Portal designed to collect and document information on Mpox cases in South Africa, streamlining reporting for healthcare professionals and public health officials.
• AEFI Reporting Dashboard Dashboard for reporting adverse events following immunisation, including COVID-19 vaccine adverse events.
• Lot Release Search Searchable database for verifying the release status of vaccine and biological product batches.
• Health Product Application Status Checker Online tool for tracking the status of health product registration applications submitted to SAHPRA.
• Health Products Variations Status Checker Online tool for checking the processing status of variation applications for registered health products.
• VET Status Checker Online tool for checking the status of veterinary medicine applications.
• Service Desk System Technical support system for handling industry inquiries and system-related issues.

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Five partnerships are on record, tiered core.

• WHO (World Health Organization)coreStrategic or Co-development PartnerSAHPRA collaborates with WHO on various regulatory initiatives including the WHO Collaborative Procedure for accelerated registration of medicines. The authority also participates in WHO pharmacovigilance programs and uses WHO-UMC systems for adverse event reporting.
• African Medicines Regulatory Harmonisation (AMRH) InitiativecoreStrategic or Co-development PartnerSAHPRA participates in the AMRH initiative which aims to harmonise medicines regulation across Africa, facilitating shared regulatory outcomes and reliance pathways.
• ZAZIBONA CollaborationcoreStrategic or Co-development PartnerSAHPRA participates in the ZAZIBONA centralised procedure, a collaboration between medicines regulatory authorities in Botswana, Zambia, Zimbabwe, Botswana, Namibia, and South Africa for joint evaluation of medicines.
• African Medicines Agency (AMA)coreStrategic or Co-development PartnerSAHPRA is involved in the Continental Listing Procedure under AMA, supporting the establishment of the African Medicines Agency for continent-wide medicines regulation.
• South African Pharmacy Council (SAPC)coreStrategic or Co-development PartnerSAHPRA collaborates with SAPC to crack down on unlawful manufacturing and distribution of unregistered medicines, including GLP-1/GIP medicines.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Tanzania Medicines and Medical Devices Authority (TMDA): Tanzania's medicines and medical devices regulator and fellow AMRH participant. Comparable to SAHPRA in African continental context, mandate and participation in cross-border regulatory reliance initiatives.
• Agência Nacional de Vigilância Sanitária (ANVISA Brazil): Brazil's health surveillance agency regulating medicines, medical devices, cosmetics and food. Comparable to SAHPRA as a national-level emerging-market regulator with a fee-based operating model and WHO-listed authority status.
• Central Drugs Standard Control Organisation (CDSCO India): India's national regulator overseeing drugs, cosmetics, medical devices and clinical trials. Comparable in mandate and emerging-market context, though operating across a far larger market than South Africa.
• National Agency for Food and Drug Administration and Control (NAFDAC Nigeria): Nigeria's national regulator for drugs, food, cosmetics and medical devices. Comparable to SAHPRA as an African national regulatory authority working through the AMRH harmonization framework and addressing similar product categories.

Direct peers

• Pharmaceuticals and Medical Devices Agency (PMDA Japan): Japan's national regulator for pharmaceuticals and medical devices. Directly comparable as a single national authority handling product registration, clinical trial review and post-market pharmacovigilance, with fee-based services similar to SAHPRA.
• Medicines and Healthcare products Regulatory Agency (MHRA): UK national regulator of medicines, medical devices and blood components; directly comparable to SAHPRA in mandate (product registration, pharmacovigilance, clinical trial oversight) and in operating as a single national authority within a World Health Organization framework.
• Health Canada / Health Products and Food Branch: Canada's federal authority responsible for regulating pharmaceuticals, medical devices, biologics and natural health products. Comparable to SAHPRA's combined scope across human medicines, devices and complementary products.
• Therapeutic Goods Administration (TGA Australia): Australia's national health products regulator covering prescription medicines, OTC, medical devices, biologics and complementary medicines. Comparable to SAHPRA in the breadth of product categories regulated and its fee-for-service operating model.

Broad incumbents

• U.S. Food and Drug Administration (FDA): The world's largest national health products regulator, with a much broader portfolio (food, cosmetics, tobacco, veterinary) than SAHPRA. Comparable as a regulatory incumbent whose standards and processes influence regulators like SAHPRA.
• European Medicines Agency (EMA): Regional medicines regulator for the European Union with centralized product approval and pharmacovigilance. Comparable to the regulatory functions SAHPRA performs, although it operates at a supranational level and across a larger market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/SAHPRA1
• YouTubeyoutube.com/channel/UCTCTKbMOVHnYbRxM03-pLEQ
• Facebookfacebook.com/sahpraza
• LinkedInlinkedin.com/company/sahpra
• Instagraminstagram.com/sahpra_za

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SAHPRA